Skip to main content
. 2015 Jul 1;102(3):639–647. doi: 10.3945/ajcn.115.110775

TABLE 1.

Baseline characteristics of OPEN study participants by allocated treatment1

Vitamin B-12 Placebo
Participants, n 99 102
Sex, M, n (%) 46 (46.5) 48 (47.1)
Age
Age, y 79.9 ± 3.52 80.1 ± 3.7
 75–79, n (%) 56 (56.6) 57 (55.9)
 ≥80, n (%) 43 (43.4) 45 (44.1)
Education
 Age at leaving, y 18.3 ± 5.3 17.8 ± 6.6
 No qualifications, n (%) 21 (21.4) 33 (33.0)
 Basic or clerical, n (%) 16 (16.3) 18 (18.0)
 Advanced or university, n (%) 33 (33.7) 19 (19.0)
 Other, n (%) 28 (28.6) 30 (30.0)
Vascular health
 Myocardial infarction in 5 y, n (%) 1 (1.0) 4 (3.9)
 Stroke in 5 y, n (%) 1 (1.0) 0
BMI, kg/m2 27.0 ± 5.6 27.5 ± 5.3
 <18.5, n (%) 1 (1.0) 0
 ≥30, n (%) 18 (18.2) 25 (24.8)
Mini-Mental State Examination score 29 (28–29)3 29 (28–29)
Current prescription drugs,4 n (%)
 Statins 32 (38.1) 35 (44.9)
 Proton-pump inhibitors 26 (31.0) 27 (34.6)
 Other relevant 1 (1.2) 2 (2.6)
Dietary pattern, n (%)
 >1 portion meat/wk 69 (73.4) 70 (72.2)
 >1 portion oily fish/wk 16 (18.0) 22 (23.4)
 >1 portion white fish/wk 21 (21.9) 18 (18.8)
 >1 portion eggs/wk 47 (48.5) 38 (39.2)
 Daily alcohol 33 (34.4) 35 (35.4)
Blood biochemical measure
 Participants, n 86 84
 Vitamin B-12, pmol/L 222.9 (197.4–268.9) 228.0 (194.7–271.0)
 Holotranscobalamin, pmol/L 50.4 (38.2–68.3) 48.8 (39.8–62.9)
 Homocysteine, μmol/L 15.9 (14.0–18.9) 16.3 (13.3–19.9)
 Folate, nmol/L 17.7 (10.8–25.4) 17.5 (11.8–25.4)
 Hemoglobin, g/L 139.8 ± 11.1 138.9 ± 12.9
1

OPEN, Older People and Enhanced Neurological Function.

2

Mean ± SD (all such values).

3

Median; IQR in parentheses (all such values).

4

Drug categories were as follows: statins (simvastatin, atorvastatin, pravastatin, and rosuvastatin); proton-pump inhibitors (omeprazole, lansoprazole, esomeprazole, rabeprazole, and pantoprazole); and other relevant drugs (amiodarone and metronidazole).